Sitagliptin is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl
peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck
Easy to read patient leaflet for sitagliptin. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Oct 15, 2015 ... Sitagliptin: learn about side effects, dosage, special precautions, and more on
Find patient medical information for sitagliptin oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Find information about a once-daily prescription pill, that along with diet and
exercise, may help lower blood sugar levels in adults with type 2 diabetes.
JANUVIA is a once-daily prescription pill that, along with diet and exercise, helps
lower blood sugar in adults with type 2 diabetes. Ask your doctor whether ...
Sep 8, 2016 ... Learn about Januvia (Sitagliptin Phosphate) may treat, uses, dosage, side effects
, drug interactions, warnings, patient labeling, reviews, and ...
May 16, 2007 ... Description, Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new
dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.
Sitagliptin is an antidiabetic used to treat diabetes. Read about sitagliptin and it's
side effects and dosage information online at Patient.
Sitagliptin is the first antidiabetic agent from the class of dipeptidyl peptidase-4
enzyme inhibitors. It increases the amount of circulating incretins, which stimulate